ATE377020T1 - Kristallines gamma-lacton der17beta-hydroxy- - Google Patents

Kristallines gamma-lacton der17beta-hydroxy-

Info

Publication number
ATE377020T1
ATE377020T1 AT03774488T AT03774488T ATE377020T1 AT E377020 T1 ATE377020 T1 AT E377020T1 AT 03774488 T AT03774488 T AT 03774488T AT 03774488 T AT03774488 T AT 03774488T AT E377020 T1 ATE377020 T1 AT E377020T1
Authority
AT
Austria
Prior art keywords
der17beta
lactone
hydroxy
crystalline gamma
gamma
Prior art date
Application number
AT03774488T
Other languages
English (en)
Inventor
Bruce Pearlman
Frederick Antosz
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE377020T1 publication Critical patent/ATE377020T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT03774488T 2002-09-19 2003-09-19 Kristallines gamma-lacton der17beta-hydroxy- ATE377020T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41187402P 2002-09-19 2002-09-19
US42559602P 2002-11-12 2002-11-12
US10/392,833 US7235655B2 (en) 2002-03-22 2003-03-21 Processes to prepare eplerenone

Publications (1)

Publication Number Publication Date
ATE377020T1 true ATE377020T1 (de) 2007-11-15

Family

ID=32180478

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03774488T ATE377020T1 (de) 2002-09-19 2003-09-19 Kristallines gamma-lacton der17beta-hydroxy-

Country Status (8)

Country Link
US (6) US7235655B2 (de)
EP (1) EP1539795B1 (de)
JP (1) JP2006505624A (de)
AT (1) ATE377020T1 (de)
AU (1) AU2003282868A1 (de)
DE (1) DE60317214T2 (de)
ES (1) ES2295663T3 (de)
WO (1) WO2004037844A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI283245B (en) * 2002-03-22 2007-07-01 Upjohn Co Processes to prepare eplerenone
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
CL2004000574A1 (es) * 2003-03-21 2005-02-11 Pharmacia Corp Sa Organizada B Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion.
US8110699B2 (en) * 2008-09-12 2012-02-07 University Of South Florida Cobalt-catalyzed asymmetric cyclopropanation of alkenes with α-nitrodiazoacetates
WO2017156132A1 (en) 2016-03-08 2017-09-14 3D Systems, Incorporated Non-isocyanate polyurethane inks for 3d printing
CN112980910B (zh) * 2021-03-19 2024-01-05 上海应用技术大学 一种在相转移催化剂体系中微生物转化11α-羟基坎利酮的方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053856A (en) 1958-10-29 1962-09-11 Shell Oil Co Epoxidation of ethylenic compounds with peroxycarboximidic acids
US3200113A (en) 1963-01-09 1965-08-10 Sterling Drug Inc 7-cyano steroids and derivatives thereof
US3300489A (en) 1964-07-24 1967-01-24 Smith Kline French Lab Steroidal c-17 spirolactones and processes and intermediates used in the preparation thereof
US3413288A (en) 1965-07-07 1968-11-26 Parke Davis & Co Process for the production of steroidal c-17 spirolactones
US3565924A (en) 1968-07-01 1971-02-23 Wisconsin Alumni Res Found 25-hydroxycholfcalciferol
US3833622A (en) 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3759791A (en) 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione
DE2404947C2 (de) 1973-02-06 1983-04-21 Roussel-Uclaf, 75007 Paris Steroidspirolactone, Verfahren zu ihrer Herstellung und deren Verwendung
FR2216273B1 (de) 1973-02-06 1977-07-22 Roussel Uclaf
US3874417A (en) * 1973-05-24 1975-04-01 Robert B Clay Pneumatic pump surge chamber
GB1455220A (de) 1973-09-14 1976-11-10 Searle & Co
DE2349022A1 (de) 1973-09-26 1975-04-10 Schering Ag Neue d-homo-steroide
FR2260569B1 (de) 1974-02-08 1978-06-16 Ugine Kuhlmann
CH631462A5 (de) 1976-03-05 1982-08-13 Schering Ag Verfahren zur herstellung von neuen steroiden der androstan- oder oestranreihe.
GB1532682A (en) 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
YU41412B (en) 1978-08-15 1987-04-30 Gist Brocades Nv Process for obtaining 17 beta-hydroxy -3-dxo-17 alpha-pregn-4-en-21-carboxylic acid
US4270994A (en) 1980-02-20 1981-06-02 G. D. Searle & Co. Electrochemical dehydrogenation of steroidal Δ3,5 enol ethers under basic conditions to provide steroidal Δ4,6 dienones
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3344057A1 (de) 1982-12-09 1984-06-14 Ciba-Geigy Ag, Basel Eine neue lactonverbindung und pharmazeutische zusammensetzungen davon, sowie verfahren zu ihrer herstellung
JPS59139400A (ja) 1983-01-31 1984-08-10 Shionogi & Co Ltd 抗アルドステロン活性ステロイド誘導体
US4559332A (en) 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
EP0123734A1 (de) 1983-04-29 1984-11-07 Gist-Brocades N.V. 17-(Isocyano-sulfonylmethylen)-Steroide, 17-(Formamido-sulfonylmethylen)-Steroide und ihre Herstellung
US4670551A (en) 1984-06-21 1987-06-02 Ciba-Geigy Corporation Epoxy steroids
KR960010793B1 (ko) 1986-10-10 1996-08-08 루쎌 위클라프 소시에떼 아노님 9-알파-히드록시 스테로이드 및 그의 제조방법
FR2610933B1 (fr) 1987-02-18 1989-06-09 Roussel Uclaf Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant
DE3903988A1 (de) * 1989-02-10 1990-08-30 Basf Ag Oxidierte diphenylheteroalkane, ihre herstellung und verwendung
US5962697A (en) * 1993-05-06 1999-10-05 Pharmacia & Upjohn Company Optically active 3-(1-(alkylamino))alkyl pyrrolidines
EP0697015A1 (de) * 1993-05-06 1996-02-21 PHARMACIA & UPJOHN COMPANY Optisch aktive 3-(1-(alkylamino)-alkyl)-pyrrolidine
US5502222A (en) 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
US5655888A (en) * 1994-10-14 1997-08-12 Tlv Co., Ltd. Pump and combination pump and trap with snap-over mechanism and double-seal outlet valve
US5565888A (en) * 1995-02-17 1996-10-15 International Business Machines Corporation Method and apparatus for improving visibility and selectability of icons
AT404597B (de) * 1995-11-24 1998-12-28 Immuno Ag Verfahren zur herstellung von proteinen
DE69637140T2 (de) 1995-12-11 2008-04-10 G.D. Searle Llc, Chicago Verfahren zur herstellung einer epoxy-verbindung
BR9714510A (pt) * 1996-12-11 2000-11-28 Searle & Co Processo e preparo de esteróides de 9,11-époxi e intermediários úteis dos mesmos
US6638937B2 (en) * 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
UA74141C2 (uk) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
AU784946B2 (en) 1999-12-08 2006-08-03 Pharmacia Corporation Eplerenone crystalline form exhibiting enhanced dissolution rate
WO2001041535A2 (en) 1999-12-08 2001-06-14 Pharmacia Corporation Eplerenone crystalline form
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
US6716829B2 (en) * 2000-07-27 2004-04-06 Pharmacia Corporation Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
TWI283245B (en) 2002-03-22 2007-07-01 Upjohn Co Processes to prepare eplerenone
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
RS20050310A (en) * 2002-11-06 2007-08-03 Pharmacia & Upjohn Company Llc., Process for preparing 7-carboxy substituted steroids
RS20050339A (sr) * 2002-11-07 2007-08-03 Pharmacia & Upjohn Company Llc., Postupci za dobijanje c-7 supstituisanih 5-androstena

Also Published As

Publication number Publication date
US20070123704A1 (en) 2007-05-31
US7235655B2 (en) 2007-06-26
ES2295663T3 (es) 2008-04-16
US7417140B2 (en) 2008-08-26
DE60317214T2 (de) 2008-08-07
US20070100140A1 (en) 2007-05-03
WO2004037844A1 (en) 2004-05-06
AU2003282868A1 (en) 2004-05-13
JP2006505624A (ja) 2006-02-16
US20040127702A1 (en) 2004-07-01
US7414127B2 (en) 2008-08-19
US20030232981A1 (en) 2003-12-18
DE60317214D1 (de) 2007-12-13
US7112670B2 (en) 2006-09-26
US7411062B2 (en) 2008-08-12
WO2004037844A8 (en) 2004-06-10
EP1539795B1 (de) 2007-10-31
EP1539795A1 (de) 2005-06-15
US20070106072A1 (en) 2007-05-10
US20070117780A1 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
HK1078588A1 (en) Process to prepare eplerenone
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
NO20052058D0 (no) Behandling av influensa.
DK1494692T3 (da) Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
ATE418554T1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
SE0301653D0 (sv) Novel compounds
HRP20050439B1 (en) New use of dextran sulfate
EP1831239B8 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carbonsäure gamma-lacton und schlüsselzwischenprodukte für dieses verfahren
NO20054535L (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
DK1817326T3 (da) Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde
BR0312522A (pt) Método para a preparação de trombina inativada por vìrus, trombina, formulação farmacêutica, e, kit farmacêutico
NO20063293L (no) Farmasoytiske forbindelser
ITMI20022022A1 (it) Analoghi di nocicettina.
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
DK1517914T3 (da) 9-alpha-substituerede estratriener som selektivt virksomme östrogener
EA200601030A1 (ru) 7α,17α-ЗАМЕЩЁННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕ
ATE328595T1 (de) Carvedilolpolymorph
PA8579401A1 (es) Derivados de 2,3-dihidro-isoindol-1-ona como inhibidores de mao-b
BRPI0410638A (pt) derivados de azitromicina
DE50309290D1 (de) Weichenstellsystem
ATE417055T1 (de) Steroid modifizierte solatriosen
ES1053443Y (es) Pijama perfeccionado.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties